Among these, ARMS is the more aggressive form, often driven by chromosomal translocations that give rise to PAX3/7-FOXO1 fusion proteins, which act as oncogenic transcription factors. This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.